Orexigen Therapeutics Inc (OREX.OQ)
OREX.OQ on NASDAQ Stock Exchange Global Select Market
7.68USD
10:56am EDT
7.68USD
10:56am EDT
Price Change (% chg)
$0.08 (+1.05%)
$0.08 (+1.05%)
Prev Close
$7.60
$7.60
Open
$7.68
$7.68
Day's High
$7.72
$7.72
Day's Low
$7.64
$7.64
Volume
60,969
60,969
Avg. Vol
334,944
334,944
52-wk High
$7.84
$7.84
52-wk Low
$3.77
$3.77
About
Orexigen Therapeutics, Inc. develops drug treatments for obesity and related disorders. Orexigen Therapeutics, Inc. develops and commercializes combinations of currently available drugs that are designed to achieve and sustain weight loss by enhancing satiety, diminishing appetite, improving energy expenditure and minimizing the... (more)
Overall
| Beta: | 2.04 |
| Market Cap (Mil.): | $719.28 |
| Shares Outstanding (Mil.): | 94.64 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| OREX.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 47.13 | 37.76 |
| EPS (TTM): | -1.31 | -- | -- |
| ROI: | -86.65 | -2.58 | 18.76 |
| ROE: | -132.46 | -2.66 | 19.59 |
Competitors
| Price | Change | |
|---|---|---|
| Abbott Laboratories (ABT.N) | $36.91 | +0.28 |
| Roche Holding Ltd. (ROG.VX) | CHF228.00 | -3.50 |
| GlaxoSmithKline plc (GSK.L) | 1,706.50p | +22.50 |
| Arena Pharmaceuticals, Inc. (ARNA.OQ) | $6.95 | 0.00 |
| Amylin Pharmaceuticals LLC (AMLN.OQ) | -- | -- |
| Alizyme plc (AZM.L) | -- | -- |
| Athersys, Inc. (ATHX.OQ) | $1.54 | +0.01 |
| NeuroSearch A/S (NEUR.CO) | kr.4.18 | +0.08 |
| Novo Nordisk A/S (NOVOb.CO) | kr.974.50 | +26.50 |
| Sanofi SA (SASY.PA) | €76.35 | -3.82 |
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: ValuEngine, Inc.
|
$25.00
|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: S&P Capital IQ Quantitative Report
|
$69.00
|
|
Provider: Pechala's Reports
|
$15.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

